Ich recommended forced degradation studies on selected novel oral hypoglycemic agents

Abstract

ICH prescribed forced degradation studies on sitagliptin and nateglinide, were carried out in accordance with ICH guidelines Q1(R2). Different LC-MS compatible HPLC methods (isocratic and gradient) were developed for separation of all the degradation products from the drug peaks as well as from each other, and for studying the degradation behavior of each drug in different forced conditions. Forced degradation (FD) studies are done to determine the intrinsic stability of the active pharmaceutical ingredients (API) as well as the final formulation. By knowing the degradation behavior one can predict the efficacy and safety profile of the pharmaceutical product, shelf life and storage conditions for the post manufacturing. The ICH guidelines are providing the basis and requirement for the conduct of forced degradation studies on new drug substance and new drug product by exposing to acid or basic hydrolysis, oxidative, photolytic and thermal degradation conditions. newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced